West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 279,300 | 270,700 | 256,100 | 242,700 | 263,700 |
| Cost of Goods | 195,700 | 187,200 | 185,700 | 178,400 | 187,000 |
| Gross Profit | 83,600 | 83,500 | 70,400 | 64,300 | 76,700 |
| Operating Expenses | 41,700 | 45,600 | 63,600 | 51,800 | 41,800 |
| Operating Income | 42,600 | 38,100 | 7,500 | 12,900 | 34,900 |
| Interest Expense | 4,200 | 4,100 | 3,800 | 3,900 | 3,900 |
| Other Income | 1,300 | 900 | 2,300 | 2,500 | 2,600 |
| Pre-tax Income | 39,700 | 34,900 | 6,000 | 11,500 | 33,600 |
| Income Tax | 10,800 | 8,500 | -200 | -800 | 7,000 |
| Net Income Continuous | 28,900 | 26,400 | 6,500 | 12,200 | 26,500 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | -500 |
| Minority Interests | 200 | 200 | N/A | N/A | N/A |
| Net Income | $28,700 | $26,200 | $6,000 | $12,200 | $26,000 |
| EPS Basic Total Ops | 0.45 | 0.41 | 0.10 | 0.19 | 0.40 |
| EPS Basic Continuous Ops | 0.45 | 0.41 | 0.10 | 0.19 | 0.40 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.01 | N/A | -0.01 |
| EPS Diluted Total Ops | 0.41 | 0.38 | 0.10 | 0.18 | 0.37 |
| EPS Diluted Continuous Ops | 0.40 | 0.37 | 0.11 | 0.17 | 0.37 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -0.01 |
| EBITDA(a) | $57,800 | $52,800 | $21,900 | $26,800 | $49,200 |